Description

Introducing Gedorab-LS: Advanced Relief for Acid Control and Digestive Comfort

Dual-Action Relief: Gedorab-LS combines Rabeprazole (20mg), a potent proton pump inhibitor, with Levosulpiride (75mg) to effectively suppress gastric acid and regulate motility, providing comprehensive relief from acid reflux and associated discomfort.

Extended Symptom Management: Sustained-release Rabeprazole ensures prolonged acid suppression, alleviating heartburn and acid regurgitation, while Levosulpiride enhances gastric emptying for consistent relief throughout the day.

Convenient Once-Daily Dosing: With a once-daily formulation, Gedorab-LS simplifies treatment adherence, improving patient compliance and optimizing therapeutic outcomes.

Proven Clinical Efficacy: Supported by clinical trials, Gedorab-LS effectively manages acid-related disorders, offering reassurance to healthcare providers and patients alike.

Pharmaceutical Excellence: Manufactured to stringent standards, Gedorab-LS upholds pharmaceutical integrity, ensuring safety, efficacy, and reliability in acid control and digestive health management by Anevay Pharmaceuticals Private Limited.